Three-dimensional (3D) chromatin architecture undergoes dynamic reorganization during mammalian gametogenesis and early embryogenesis. While mouse studies have shown species-specific patterns as well as mechanisms underlying de novo organization, these remain poorly characterized in humans. Although RNA polymerases II and III have been shown to regulate chromatin structure, the potential role of RNA polymerase I (Pol I), which drives ribosomal RNA production, in shaping 3D genome organization during these developmental transitions has not been investigated. We employed a modified low-input in situ Hi-C approach to systematically compare 3D genome architecture dynamics from gametogenesis through early embryogenesis in human and mouse. Complementary Smart-seq2 for low-input transcriptomics, CUT&Tag for Pol I profiling, and Pol I functional inhibition assays were performed to elucidate the mechanisms governing chromatin organization. Our study revealed an extensive reorganization of the 3D genome from human oogenesis to early embryogenesis, displaying significant differences with the mouse, including dramatically attenuated topologically associating domains (TADs) at germinal vesicle (GV) stage oocytes. The 3D genome reconstruction timing is a fundamental difference between species. In human, reconstruction initiates at the 4-cell stage embryo in human, while in mouse, it commences at the 2-cell stage embryo. We discovered that Pol I is crucial for establishing the chromatin structures during mouse embryogenesis, but not in human embryos. Intriguingly, the absence of Pol I transcription weakens TAD structure in mouse female germline stem cells, whereas it fortifies it in human counterparts. These observed interspecies distinctions in chromatin organization dynamics provide novel insights into the evolutionary divergence of chromatin architecture regulation during early mammalian development. Our findings provide mechanistic insights into species-specific chromatin organization during germ cell and embryonic development and have potential implications for fertility preservation and birth defect prevention.
Snai2 is a transcription factor that inhibits the proliferation of cervical cancer cells and tumor growth. The expression of Snai2 inhibited the expression of β-catenin and impaired Wnt/β-catenin signaling pathway activity. The results of the RNA sequence in Snai2-overexpressing cervical cancer cells implied a strong correlation between Snai2 and TRIM31 with ubiquitin ligase activity. However, the mechanism by which Snai2 regulates TRIM31 remains unclear. In cervical cancer cells, TRIM31 is highly expressed in cervical cancer cells and carcinoma tissues and promotes the proliferation of cervical cancer cells. Furthermore, overexpression or interference with TRIM31 could increase or inhibit the expression of downstream proteins of the classical Wnt signaling pathway, such as β-catenin, cyclin D1 and c-Myc. To the best of our knowledge, rescue of TRIM31 in Snai2-overexpressing cervical cancer cells restored the expression of β-catenin, cyclin D1 and c-Myc. Finally, Snai2 was shown to transcriptionally inhibit the expression of TRIM31 by recognizing and binding to its E-box located in the promoter region. Our findings provide new evidence that TRIM31 may promote cell proliferation and that Snai2 may impair Wnt/β-catenin signaling pathway activity through the transcriptional inhibition of TRIM31. These findings provide new ideas for the regulation of tumor growth and targeted therapy by Snai2-TRIM31 and the Wnt/β-catenin pathway axis.
Clinically, even in patients diagnosed with non-obstructive azoospermia, spermatogenesis may be present in some seminiferous tubules, which gives the patient hope of having biological offspring of his own. However, there is still a blank for high-precision detection technologies to support accurate diagnosis and effective treatment. In this work, we successfully developed a minimally invasive fine needle detection memristive device that features a structure composed of Ag/C40H56-MnO2/FTO by utilizes the organic-inorganic heterojunction as functional layer. The as-prepared memristor exhibits remarkable resistance switching (RS) performance, which serves as solid evidence of its efficacy in detecting sperm within the seminiferous tubules. Further, the RS characteristics of the memristor can be effectively modulated by adjusting the bias voltage amplitude, emulating the sensing dynamics of artificial neural synapses. By theoretical analyses, it is suggested that the RS mechanism involves synergistic effects of ion migration, Ohmic conduction, Fowler-Nordheim tunneling, and space-charge-limited current transport. Finally, a painless integrated detection device with micro needles was designed, which not only lays the foundation for novel reproductive health monitoring technologies, but also opens new avenues for bioelectronic integration in clinical diagnostics. Therefore, these findings highlight the potential of memristive systems to bridge neuromorphic engineering with precision medicine.
The most common cause of female infertility is ovulatory disorders, accounting for approximately 57.5% of female infertility diagnoses, indicating that ovulation monitoring plays a pivotal role in fertility management. However, almost all of the current monitoring techniques face limitations in real-time accuracy and continuous data acquisition, hindering the development of reproductive medicine. In this work, it is first designed a noninvasive and real-time ovulation monitoring approach utilizing an Ag/HfO2/FTO memristor by using HfO2 as the functional layer of the device. By analyzing the I–V curve characteristics of saliva and urine samples across follicular, ovulatory, and luteal phases, it can be identified distinct peak current signatures with stable bipolar resistive switching over 100 cycles, which addresses critical limitations of current methods by offering noninvasive and real-time detection of the fertility window. Further, the as-proposed de novo theoretical mechanism is the modulation of the memristive switching behavior through hormone-driven ionic variations in biofluids, enabling real-time detection of ovulation phases. Therefore, this technology can be integrated into assisted reproductive technologies and smart home appliances, such as intelligent toilets and smart electric toothbrushes for noninvasive, real-time, and dynamic ovulation monitoring.